Browse the evidence

The global prevalence of obesity is increasing and is closely related to life-shortening chronic illnesses.

Public health initiatives should focus on obesity prevention to reduce chronic disease risk.

Therapies such as thiazolidinedione, insulin secretagogue, and insulin are less suitable for individuals with obesity and T2D as they are associated with weight gain.

Clinicians should avoid prescribing therapies that promote weight gain in obese T2D patients.

Incorporating MRs into a weight loss intervention leads to reductions in LDL cholesterol by -0.18 mmol/L.

Meal replacements may improve lipid profiles in individuals with metabolic syndrome.

An unhealthy lifestyle increases the risk of developing type 2 diabetes more significantly in women than in men.

Healthcare providers should emphasize lifestyle changes, particularly for women, to reduce diabetes risk.

Diabetes increases the risk of developing cardiovascular diseases in women by 30-50%.

Clinicians should monitor cardiovascular health closely in female diabetes patients.

The guidelines focus on cardiovascular risk stratification and management of cardiovascular risk factors in diabetes.

Focus on cardiovascular risk factors is essential for diabetes management.

The guidelines aim to reduce the risk of heart failure and chronic kidney disease in individuals with diabetes.

Implementing these guidelines can help mitigate serious health risks in diabetic patients.

Weight loss was observed in 52.8% of patients, with a mean change of −0.9 ± 8.2 kg.

Practitioners may see moderate weight loss in a significant portion of patients.

The DG3D study is a 12-month, single-masked, three-arm randomized behavioral nutrition intervention.

The study's design allows for robust evaluation of dietary interventions.

Post-intervention, adherence to the Mediterranean diet increased by 1.09 ± 2.56 points (8.55 points).

The increase in adherence suggests that educational interventions can be effective in improving dietary habits.

Males had the maximum decrease in weight in the age group of 20–30 years (mean loss −2.63 kg), while females had the maximum weight loss in the 50–60-year group (mean loss −2.97 kg).

Weight loss varies by age and gender, which may inform targeted interventions.

Despite improvements, a considerable proportion of subjects still have high-risk levels, indicating the importance of continuing and prolonged lifestyle modification.

Ongoing lifestyle modifications are crucial for maintaining health improvements in prediabetic individuals.

Metformin showed lower risks for cardiovascular disease, acidosis/serious infection, and all-cause mortality compared to insulin and other oral hypoglycaemic agents.

Metformin should be considered as a first-line treatment for T2D due to its favorable risk profile.

Der Taillenumfang und das Verhältnis von Taillenumfang zu Hüft- oder Körpergröße sind wichtige Prädiktoren für kardiovaskuläre Risiken.

Health practitioners should consider waist measurements in assessing cardiovascular risk.

Lebensstilinterventionen sind essenziell, während medikamentöse und operative Ansätze Potenzial zur Reduktion kardiovaskulärer Ereignisse zeigen.

Practitioners should implement lifestyle changes while considering pharmacological and surgical options for patients.

Participants with 3 and 6-7 cardiovascular risk factors controlled had lower risks of all-cause mortality, with HRs of 0.77 and 0.43, respectively.

Practitioners should encourage patients to manage multiple cardiovascular risk factors to reduce mortality risk.

Improved control of cardiovascular risk factors is associated with reduced mortality, with an HR of 0.86 compared to stable low control.

Encouraging improvements in cardiovascular risk factor control can significantly lower mortality risk.

Participants in the highest quartile of time-weighted average risk factor control had 47% lower mortality compared to those in the lowest quartile.

Maintaining high levels of cardiovascular risk factor control is crucial for reducing mortality risk.

The PAP intervention was found to be cost-effective and comparable in value to standard care.

PAP can be a viable and cost-effective option for healthcare providers to improve patient outcomes.

The model combines 43 multi-factors, including laboratory and lifestyle features.

Incorporating both laboratory and lifestyle factors can improve T2D risk prediction.

Quality of life, as measured by the Short Form-36 (SF-36), improved in the experimental group.

Improving quality of life is an important benefit of structured exercise for diabetic patients.

GLP-1 receptor agonists reduce central adiposity, SBP, DBP, and insulin resistance.

Practitioners should consider GLP-1 receptor agonists for improving metabolic health in this population.

Insulin resistance compromises the body's normal response to insulin, leading to multiple diseases including Type 2 diabetes mellitus.

Practitioners should recognize insulin resistance as a critical factor in managing metabolic diseases.

Insulin resistance leads to a metabolic profile that is strongly atherogenic, accelerating atherosclerosis and cardiovascular diseases.

Understanding the atherogenic effects of insulin resistance can guide cardiovascular risk management.